LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 44 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $21,027,000 | -0.6% | 21,600,000 | 0.0% | 1.44% | +50.3% |
| Q1 2022 | $21,148,000 | -3.2% | 21,600,000 | 0.0% | 0.96% | -27.1% |
| Q4 2021 | $21,837,000 | +0.2% | 21,600,000 | 0.0% | 1.32% | -1.6% |
| Q3 2021 | $21,800,000 | +1.9% | 21,600,000 | 0.0% | 1.34% | +14.6% |
| Q2 2021 | $21,402,000 | +71.8% | 21,600,000 | +80.0% | 1.17% | +31.0% |
| Q1 2021 | $12,456,000 | – | 12,000,000 | – | 0.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CANYON CAPITAL ADVISORS LLC | 40,000,000 | $38,988,000 | 1.44% |
| Penn Mutual Asset Management, LLC | 1,204,000 | $1,174,000 | 1.36% |
| TFG Asset Management GP Ltd | 21,600,000 | $21,148,000 | 0.96% |
| PALISADE CAPITAL MANAGEMENT, LP | 10,006,000 | $9,832,000 | 0.23% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 11,645,000 | $11,431,000 | 0.22% |
| OAKTREE CAPITAL MANAGEMENT LP | 20,353,000 | $19,882,000 | 0.21% |
| Wellesley Asset Management | 2,304 | $2,245,000 | 0.15% |
| DAVIDSON KEMPNER CAPITAL MANAGEMENT LP | 10,000,000 | $9,719,000 | 0.12% |
| SSI INVESTMENT MANAGEMENT LLC | 2,000,000 | $1,942,000 | 0.11% |
| Cutler Capital Management, LLC | 300,000 | $291,000 | 0.10% |